Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, ...

Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed. Given this risk, we thought we'd take a look at whether Annovis Bio ...

In an exciting development within the healthcare and biotechnology sectors, Evexia Lifecare Limited (Evexia) has signed a ...

The companies signed a term sheet on November 8, 2024, detailing Evexia's strategic acquisition plan. As part of the ...

Pharma chemicals manufacturer Evexia Lifecare has bought majority stake in Diponed Bio. Evexia acquired 18,600 fresh equity ...

CSL shares have long been a darling of the ASX, boasting a stellar track record on the chart. Are they a buy? Let's see.